Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Martina Petráčková"'
Autor:
Martin Štach, Robert Pytlík, Kristýna Šmilauerová, Jana Rychlá, Martin Mucha, Jan Musil, Abhishek Koladiya, Matěj Nemec, Martina Petráčková, Iva Kaštánková, Pavla Pecherková, Lucie Šrámková, Kamila Polgárová, Marek Trněný, Petr Lesný, Jan Vydra, Pavel Otáhal
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
Tisagenlecleucel (tisa-cel) is a CD19-specific CAR-T cell product approved for the treatment of relapsed/refractory (r/r) DLBCL or B-ALL. We have followed a group of patients diagnosed with childhood B-ALL (n = 5), adult B-ALL (n = 2), and DLBCL (n =
Externí odkaz:
https://doaj.org/article/1d9dc7c6b478480589b2506dafb816b3
Autor:
Kateřina Kuželová, Barbora Brodská, Jana Marková, Martina Petráčková, Johannes Schetelig, Šárka Ransdorfová, Zdenka Gašová, Cyril Šálek
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
The immune system is important for elimination of residual leukemic cells during acute myeloid leukemia (AML) therapy. Anti-leukemia immune response can be inhibited by various mechanisms leading to immune evasion and disease relapse. Selected marker
Externí odkaz:
https://doaj.org/article/4ab2548210ad4b5ab7f7e51955cc9c58
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
In the recent past, it has repeatedly been reported that CD4 cells play an important role in the immunology of chronic myeloid leukaemia. It was therefore of interest to test their activity in an animal model using bcr-abl-transformed cells. BALB/c m
Externí odkaz:
https://doaj.org/article/3cd685e05cdb41c9a813a558b351fa33